Extended-Release Buprenorphine Treatments for Opioid Use Disorder
Description
This training provides healthcare teams with information on the available extended-release injectable buprenorphine formulations for the treatment of opioid use disorder and how to implement them into clinical practice.
Topics include the pharmacology and side effects of extended-release injectable buprenorphine formulations; storage, administration, and patient selection processes; dosage, initiation, and maintenance for patients using weekly and monthly injectable doses; and the workflows and administrative tasks involved in implementing extended-release injectable buprenorphine in healthcare settings.
Objectives
Following this training, participants will have the knowledge to:
- Explain the pharmacology and side effects of injectable buprenorphine formulations.
- Recall processes of patient selection, storage, and administration of injectable buprenorphine.
- Develop basic understanding of dosing, initiation and maintenance using weekly and monthly injectable buprenorphine.
- Identify workflows and administrative requirements for implementing injectable buprenorphine within healthcare settings.
For trainings that indicate Continuing Education Units (CEUs) are available, contact the organizer and/or the Vermont Office of Professional Regulation to verify that the credits will count toward the continuing education requirements of your licensure or certification.
Virtual
Event Details